NCT04256538View on ClinicalTrials.gov

Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD)

CompletedOBSERVATIONAL
Enrollment

179

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

June 30, 2020

Conditions
Inflammatory Bowel Diseases
Trial Locations (1)

310009

2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT04256538 - Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD) | Biotech Hunter | Biotech Hunter